GlassScriptPhysician profile
Rhunjay J Yu
NPI 1255527024
$62,870.43
in general payments reported to CMS, 2019-2025
33 companies · $1,330 in 2025
The $1,330 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $19K · 2021: $17K · 2022: $4,543 · 2023: $1,045 · 2024: $762 · 2025: $1,330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,136.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $27,612.41 | 2019-2020 | |
| Intuitive Surgical, INC. | $20,880.39 | 2019-2025 | Da Vinci Surgical System |
| Teleflex LLC | $10,456.50 | 2020-2023 | Urolift |
| Sumitomo Pharma America, INC. | $725.64 | 2023-2025 | Gemtesa, Orgovyx |
| Rochester Medical Corporation | $350.11 | 2019-2022 | |
| Janssen Biotech, INC. | $321.77 | 2019-2025 | Erleada |
| Procept Biorobotics Corporation | $306.52 | 2024-2025 | Aquabeam System |
| Astellas Pharma US INC | $239.91 | 2019-2022 | |
| Abbvie INC. | $222.65 | 2019-2025 | Lupron Depot |
| Boston Scientific Corporation | $220.68 | 2019-2023 | Rezum Generator, Spaceoar Vue System - 10ml |
| Telix Pharmaceuticals | $199.21 | 2024-2025 | Illuccix |
| Ferring Pharmaceuticals INC. | $177.48 | 2024-2025 | Adstiladrin |
| C. R. Bard, INC. & Subsidiaries | $124.20 | 2019-2024 | Bard Urinary Drainage Bag |
| Myriad Genetic Laboratories, INC. | $123.95 | 2022-2025 | Prolaris |
| Ethicon US, LLC | $123.37 | 2025 | Vistaseal, Stratafix, Dermabond Prineo |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $92.94 | 2023-2025 | |
| Olympus America INC. | $76.58 | 2022-2025 | Itind System |
| Profound Medical Corp. | $70.90 | 2025 | Tulsa-Pro |
| Urogen Pharma, INC. | $70.27 | 2022 | |
| Smith+Nephew, INC. | $66.31 | 2023-2025 | Stravix Pl, Grafix Pl, Stravix |
| Biotissue Holdings INC. | $60.74 | 2024-2025 | |
| Tolmar, INC. | $58.77 | 2023 | |
| Medtronic, INC. | $51.07 | 2024 | Signia |
| Becton, Dickinson and Company | $37.35 | 2024 | Arista Ah Flexitip |
| Immunitybio, INC. | $31.45 | 2024 | |
| Progenics Pharmaceuticals, INC. | $27.23 | 2025 | |
| Accord Healthcare, INC. | $23.81 | 2024 | |
| Myovant Sciences INC. | $22.68 | 2022 | |
| Blue Earth Diagnostics | $21.80 | 2022 | |
| Dendreon Pharmaceuticals LLC | $21.39 | 2020 | |
| Coloplast Corp | $21.38 | 2024 | |
| Allergan, INC. | $16.57 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.40 | 2023 | Lynparza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rhunjay Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.